Arvee Laborat. Share Price ₹172 | P/E 49.2

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Arvee Laborat.

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	12.56	7.60	8.91	7.70	6.14	10.60	12.53	8.91	6.45	7.48	3.45	9.78	10.80
Expenses +	11.40	6.62	8.22	7.17	5.35	9.06	11.03	8.57	6.23	7.14	3.33	8.15	9.70
Operating Profit	1.16	0.98	0.69	0.53	0.79	1.54	1.50	0.34	0.22	0.34	0.12	1.63	1.10
OPM %	9.24%	12.89%	7.74%	6.88%	12.87%	14.53%	11.97%	3.82%	3.41%	4.55%	3.48%	16.67%	10.19%
Other Income +	0.06	0.09	0.09	0.19	0.21	0.11	0.16	0.19	0.21	0.17	0.23	0.14	0.15
Interest	0.07	0.07	0.08	0.05	0.05	0.08	0.05	0.05	0.07	0.04	0.04	0.07	0.08
Depreciation	0.48	0.35	0.42	0.35	0.37	0.31	0.30	0.28	0.27	0.29	0.30	0.30	0.31
Profit before tax	0.67	0.65	0.28	0.32	0.58	1.26	1.31	0.20	0.09	0.18	0.01	1.40	0.86
Tax %	100.00%	24.62%	25.00%	25.00%	81.03%	25.40%	25.19%	25.00%	22.22%	5.56%	0.00%	-30.71%	38.37%
Net Profit +	0.01	0.49	0.21	0.24	0.12	0.94	0.98	0.15	0.07	0.17	0.01	1.83	0.52
EPS in Rs	0.01	0.44	0.19	0.22	0.11	0.85	0.89	0.14	0.06	0.15	0.01	1.66	0.47

Financials of Arvee Laborat.

Annual income statement trend

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	26.82	34.44	47.78	54.90	45.42	47.38	40.33	61.35	30.35	38.49	31.51
Expenses +	21.83	28.54	40.61	48.73	39.40	41.31	34.65	54.06	27.41	34.88	28.32
Operating Profit	4.99	5.90	7.17	6.17	6.02	6.07	5.68	7.29	2.94	3.61	3.19
OPM %	18.61%	17.13%	15.01%	11.24%	13.25%	12.81%	14.08%	11.88%	9.69%	9.38%	10.12%
Other Income +	0.10	0.51	0.23	0.35	0.35	0.56	0.46	1.35	0.64	0.66	0.68
Interest	3.07	3.48	3.33	1.63	0.99	0.58	0.37	0.39	0.25	0.25	0.23
Depreciation	1.49	2.07	2.15	2.35	2.29	2.41	2.32	2.08	1.50	1.15	1.21
Profit before tax	0.53	0.86	1.92	2.54	3.09	3.64	3.45	6.17	1.83	2.87	2.43
Tax %	66.04%	-81.40%	43.23%	11.02%	25.89%	26.37%	25.51%	33.23%	42.62%	25.09%	-3.70%
Net Profit +	0.19	1.55	1.09	2.26	2.30	2.68	2.57	4.12	1.05	2.15	2.53
EPS in Rs	0.23	1.91	0.99	2.05	2.09	2.43	2.33	3.74	0.95	1.95	2.30
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials of Arvee Laborat.

Capital structure and asset base

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4.05	4.05	5.51	5.51	5.51	11.02	11.02	11.02	11.02	11.02	11.02
Reserves	-1.41	0.15	8.69	10.95	13.25	10.42	12.92	17.04	18.09	20.24	22.77
Borrowings +	25.32	24.99	16.15	12.87	3.87	8.88	3.13	1.00	1.00	1.03	1.11
Other Liabilities +	7.25	6.49	13.77	7.81	11.00	10.73	11.61	9.63	8.45	5.29	8.36
Total Liabilities	35.21	35.68	44.12	37.14	33.63	41.05	38.68	38.69	38.56	37.58	43.26
Fixed Assets +	13.15	16.88	14.88	12.65	13.18	13.81	13.84	12.68	12.67	15.27	16.72
CWIP	4.30	0.00	1.18	2.32	1.78	0.97	0.98	1.53	2.62	0.73	0.90
Investments	0.00	0.00	0.00	1.95	3.09	2.03	0.00	0.00	0.00	0.00	0.00
Other Assets +	17.76	18.80	28.06	20.22	15.58	24.24	23.86	24.48	23.27	21.58	25.64
Total Assets	35.21	35.68	44.12	37.14	33.63	41.05	38.68	38.69	38.56	37.58	43.26

Financials of Arvee Laborat.

Operating, investing and financing cash movement

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	4.03	6.02	9.46	10.31	1.71	0.68	2.93	3.66	-0.21	-0.12
Cash from Investing Activity +	-1.40	-1.23	-2.85	-3.08	-0.60	0.06	-1.26	-2.16	-1.32	0.50
Cash from Financing Activity +	-2.92	-3.78	-4.92	-9.90	4.52	-6.06	-2.42	-0.19	-0.12	-0.16
Net Cash Flow	-0.29	1.00	1.68	-2.67	5.63	-5.32	-0.75	1.31	-1.64	0.23
Free Cash Flow	2.54	4.68	7.96	8.02	-0.53	-1.68	1.47	1.07	-2.06	-2.95
CFO/OP	57%	96%	158%	184%	44%	29%	64%	139%	10%	3%

Financials of Arvee Laborat.

Working capital efficiency and return ratios

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	82.61	87.12	118.25	52.66	52.40	60.70	109.78	72.94	73.48	79.66	121.05
Inventory Days	155.08	104.53	99.61	42.90	80.96	91.96	93.24	42.29	159.02	80.31	228.81
Days Payable	130.73	98.14	150.03	55.84	125.63	118.08	160.12	73.30	164.49	57.72	158.60
Cash Conversion Cycle	106.96	93.50	67.84	39.72	7.72	34.59	42.90	41.94	68.01	102.25	191.26
Working Capital Days	30.08	30.84	30.79	-6.52	10.29	-10.63	49.96	70.44	95.97	103.55	166.92
ROCE %		15.19%	17.64%	13.67%	14.90%	14.92%	12.89%	23.34%	6.83%	9.58%	7.92%

Solar Industries India Ltd (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
Indo Borax & Chemicals Ltd (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

Arvee Laborat. Share Price & Earnings Call Analysis